BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6154752)

  • 1. H-2D control of leukaemia susceptibility: mechanism and implications.
    Meruelo D
    J Immunogenet; 1980 Feb; 7(1):81-90. PubMed ID: 6154752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for elevated H-2 antigen expression in resistance to neoplasia caused by radiation-induced leukemia virus. Enhancement of effective tumor surveillance by killer lymphocytes.
    Meruelo D
    J Exp Med; 1979 Apr; 149(4):898-909. PubMed ID: 219130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased synthesis and expression of H-2 antigens on thymocytes as a result of radiation leukemia virus infection: a possible mechanism for H-2 linked control of virus-induced neoplasia.
    Meruelo D; Nimelstein SH; Jones PP; Lieberman M; McDevitt HO
    J Exp Med; 1978 Feb; 147(2):470-87. PubMed ID: 75239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of H-2 antigen expression on thymocytes during leukemia development by radiation leukemia virus.
    Katz E; Peled A; Haran-Ghera N
    Leuk Res; 1985; 9(10):1219-25. PubMed ID: 2999517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulation of murine H-2Dd expression by activation transcription factor 1 and cAMP response element binding protein.
    Ishiguro N; Brown GD; Ishizu A; Meruelo D
    J Immunol; 1998 Jun; 160(12):5907-14. PubMed ID: 9637503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel DNA binding activity is elevated in thymocytes expressing high levels of H-2Dd after radiation leukemia virus infection.
    Nobunaga T; Brown GD; Morris DR; Meruelo D
    J Immunol; 1992 Aug; 149(3):871-9. PubMed ID: 1634776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo stimulation of H-2Dd expression following RadLV infection of thymocytes: increased transcription and DNA-binding activity to sequences 5' of the Dd gene.
    Brown GD; Nobunaga T; Morris DR; Meruelo D
    Res Immunol; 1991; 142(5-6):431-40. PubMed ID: 1754716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic control of radiation leukemia virus-induced tumorigenesis. I. Role of the major murine histocompatibility complex, H-2.
    Meruelo D; Leiberman M; Ginzton N; Deak B; McDevitt HO
    J Exp Med; 1977 Oct; 146(4):1079-87. PubMed ID: 197195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased H-2Dd expression following infection by a molecularly cloned ecotropic MuLV.
    Brown GD; Egan G; Dowling T; Meruelo D
    Immunogenetics; 1990; 31(2):94-103. PubMed ID: 2154401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation transcription factor 1 involvement in the regulation of murine H-2Dd expression.
    Ishiguro N; Brown GD; Meruelo D
    J Biol Chem; 1997 Jun; 272(25):15993-6001. PubMed ID: 9188502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H-21-linked control of immunological resistance to viral leukemogenesis as a response to preleukemic cells.
    Lonai P; Katz E; Peled A; Haran-Ghera N
    Immunogenetics; 1981 Mar; 12(5-6):423-32. PubMed ID: 6260638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conservation of the H-2 BF1 binding motif 5' of the H-2Ds, Ks and Dq genes.
    Brown GD; Morris DR; Meruelo D
    Eur J Immunogenet; 1997 Aug; 24(4):241-57. PubMed ID: 9306093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G(AKSL2): a new cell surface antigen of the mouse related to the dualtropic mink cell focus-inducing class of murine leukemia virus detected by naturally occurring antibody.
    Stockert E; DeLeo AB; O'Donnell PV; Obata Y; Old LJ
    J Exp Med; 1979 Jan; 149(1):200-15. PubMed ID: 216764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological and immunochemical studies of H-2 allospecificities on K36, a syngeneic tumour of AKR.
    Schmidt W; Festenstein H
    J Immunogenet; 1980 Feb; 7(1):7-17. PubMed ID: 6154751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of non-H-2-linked genes on anti-virus immune responses and long-term survival in mice persistently infected with E-55+ murine leukemia virus.
    Avidan N; Tumas-Brundage KM; Sieck TG; Prystowsky MB; Blank KJ
    Virology; 1995 Aug; 211(2):507-15. PubMed ID: 7645254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
    Manjunath R; Graziano RF; Green WR
    J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplified expression of murine leukemia virus (MuLV)-coded antigens on thymocytes and leukemia cells of AKR mice after infection by dualtropic (MCF) MuLV.
    O'Donnell PV; Nowinski RC; Stockert E
    Virology; 1982 Jun; 119(2):450-64. PubMed ID: 6177096
    [No Abstract]   [Full Text] [Related]  

  • 19. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.